BioSpace News Archive

Parathyroid disease is characterized with abnormalities of serum calcium. Hyperparathyroidism, hypoparathyroidism, and parathyroid cancer are the three types of parathyroid disease.

HbA1c (hemoglobin A1c) is made from the non-enzymatic glycation of free amino groups at the N-terminus of the β-chain of hemoglobin A

The global biomarkers market is witnessing a tremendous rise in its valuation, thanks to the increase in diagnostic applications of biomarkers.

Hypodermic needles have long been manufactured and used in a specific standard format over the years.

BetterLife Pharma Inc., an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, announces it has entered into an agreement with Eurofins Discovery for TD-0148A’s U.S. FDA Investigational New Drug -enabling pharmacology studies.

Responses in 6 out of 9 patients evaluated provide exciting evidence that BI-1206 has the potential to restore activity of rituximab in non-Hodgkin’s lymphoma patients who have relapsed after treatment with rituximab

ImaginAb Inc, a leading global provider of immuno-oncology imaging agents and NEUVOGEN, an immuno-oncology company developing next generation therapeutic whole cell cancer vaccines, announced they have signed a multi-year non-exclusive licensing agreement.

Finalized the technical development of modia™, a digital therapy for opioid use disorder, for which Orexo owns the exclusive global rights

XPhyto Therapeutics Corp. is pleased to announce its drug formulation and delivery business strategy and milestones for 2021.

Biofidelity Ltd announces the appointment of Wendy J. Levin MD MS as Chief Medical Officer, based in the US. Following Biofidelity’s recent Series A financing, supported by experienced investors BlueYard Capital, Longwall Ventures and Agilent Technologies, the Company is now focused on expanding its executive team as it works towards launch of the Identi-Lung panel in 2021.